A Study of Toripalimab or Combining With Temozolomide?iv? in the Treatment of Advanced/Metastatic Malignant Melanoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Malignant Melanoma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04884997
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Yulong Zheng, PhD First Affiliated Hospital of Zhejiang University
Get Well Soon